A Multicentre Comparison of Flurbiprofen and Naproxen in Rheumatoid Arthritis: A Four-Week Study in 118 Patients

Author:

Ligniere G Cherie1,Còlamussi V2,Cozzolongo A C3,Loizzi P3,Frizziero L4,Mattara L5,Zorzin L6

Affiliation:

1. Cattedra di Reumatologia, – Universitá di Milano, Italy

2. Divisione di Mediana, – Ospedale S. Giuseppe, – Copparo (FE), Italy

3. Cattedra di Reumatologia, – Università di Bari, Italy

4. Centro Traumatologico Ortopedico, – Bologna, Italy

5. Divisione di Reumatologia, – Ospedale Al Mare, – Venezia Lido, Italy

6. Istituto di Reumatologia, – Università di Roma, Italy

Abstract

One-hundred and eighteen patients with rheumatoid arthritis were treated for 4 weeks with flurbiprofen 300 mg/day (sixty patients) or naproxen 750 mg/day (fifty-eight patients) in a six-centre randomized trial. Flurbiprofen proved to be more effective than naproxen in reducing morning stiffness (p < 0·01), Ritchie articular index (p < 0·01) and number of swollen joints (p < 0·05) and in relieving night pain (p < 0·01). The incidence and severity of side-effects, mainly gastric, were both low and similar with flurbiprofen (17%) and naproxen (19%).

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3